Old Web
English
Sign In
Acemap
>
Paper
>
A Phase 1 Clinical Trial of Oral Eltanexor in Patients with Relapsed or Refractory Multiple Myeloma.
A Phase 1 Clinical Trial of Oral Eltanexor in Patients with Relapsed or Refractory Multiple Myeloma.
2021
Robert F. Cornell
Rachid Baz
Joshua Richter
Adriana C Rossi
Dan T. Vogl
Christine Chen
Chaim Shustik
Mariano J. Alvarez
Yao Shen
Thaddeus J. Unger
Osnat Ben-Shahar
Hongwei Wang
Erkan Baloglu
William Senapedis
Xiwen Ma
Yosef Landesman
Xiang Bai
Justin C. Bader
Hongmei Xu
Tracey Marshall
Hua Chang
Christopher J. Walker
Jatin P. Shah
Sharon Shacham
Michael Kauffman
Craig C. Hofmeister
Keywords:
Refractory Multiple Myeloma
severe acute respiratory syndrome coronavirus 2
Oncology
2019 20 coronavirus outbreak
Internal medicine
Coronavirus disease 2019
MEDLINE
in patient
Phases of clinical research
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
6
References
0
Citations
NaN
KQI
[]